What lies ahead for vaccines

Contemporary Pediatrics sat down with editor in chief Dr. Tina Q. Tan to discuss the approval of the Pfizer/BioNTech vaccine for use in many children, as well as what lies ahead in the vaccine pipeline for the pediatric population.

The news of the availability of the Pfizer/BioNTech COVID-19 vaccine for children ages 5-11 was received with joy by pediatricians and many parents. Vaccines in the pipeline could bring the same luck if they are found to be safe and effective.

Contemporary Pediatrics sat down with editor in chief Dr. Tina Q. Tan to discuss the approval of the Pfizer/BioNTech vaccine for use in many children, as well as what lies ahead in the vaccine pipeline for the pediatric population.

Comments are closed.